Corbus CBO granted RSUs and stock options
Corbus Pharmaceuticals Holdings, Inc. reported that Chief Business Officer Nishant C. Saxena received new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corbus Pharmaceuticals Holdings, Inc. reported that Chief Business Officer Nishant C. Saxena received new equity awards. On May 21, 2026, he was granted 58,300 restricted stock units (RSUs) that will settle in common shares, bringing his direct common stock holdings to 61,800 shares.
The RSUs vest 25% on each of the first four anniversaries beginning May 21, 2027, with partial acceleration possible if he is terminated without cause after the first vesting date. He was also granted options for 192,300 shares of common stock at an exercise price of $11.51 per share, expiring in 2036, which vest 25% on May 21, 2027 and the remaining 75% in equal monthly installments over 36 months starting June 21, 2027.
Insider Trade Summary
Grant/Award: 250,600 shares
Grant/Award
2 txns
Insider
Saxena Nishant C
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock options (right to buy) | 192,300 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.0001 per share | 58,300 | $0.00 | $0.00 |
Holdings After Transaction:
Stock options (right to buy) — 192,300 contracts (Direct);
Common Stock, par value $0.0001 per share — 61,800 shares (Direct)
Footnotes (3)
- F1. On May 21, 2026, the Reporting Person was granted 58,300 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth annual anniversary beginning on May 21, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a prorata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service.
- F2. This amount includes 58,300 unvested RSUs granted on May 21, 2026.
- F3. The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on May 21, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on June 21, 2027.
Key Figures
RSU grant: 58,300 RSUs
Post-grant common shares: 61,800 shares
Option grant size: 192,300 options
+3 more
6 metrics
RSU grant
58,300 RSUs
Granted May 21, 2026, vesting annually over four years
Post-grant common shares
61,800 shares
Direct holdings after RSU grant
Option grant size
192,300 options
Granted May 21, 2026 under 2024 Equity Compensation Plan
Option exercise price
$11.51 per share
Strike price for 192,300 stock options
Option expiration
May 21, 2036
Expiration date of granted stock options
Initial option vesting
25% on May 21, 2027
First vesting tranche for stock options
Key Terms
restricted stock units ("RSUs"), vesting, Equity Compensation Plan, stock options (right to buy), +1 more
5 terms
restricted stock units ("RSUs") financial
"the Reporting Person was granted 58,300 restricted stock units ("RSUs"), which will be settled in shares of common stock"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vesting financial
"25% of the RSUs shall vest on each of the first, second, third and fourth annual anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Equity Compensation Plan financial
"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan."
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
stock options (right to buy) financial
"Stock options (right to buy)"
exercise price financial
"conversion or exercise price of 11.5100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Corbus (CRBP) grant to its Chief Business Officer?
Corbus granted Chief Business Officer Nishant C. Saxena 58,300 restricted stock units and stock options for 192,300 shares. Both awards were made on May 21, 2026 as part of his compensation and are subject to multi-year vesting schedules.
How do the 58,300 RSUs granted to CRBP’s Nishant Saxena vest?
The 58,300 RSUs vest in four equal annual installments of 25% each, starting May 21, 2027. Each year on that date, another quarter of the RSUs vests, subject to continued service with Corbus Pharmaceuticals Holdings, Inc.
Is there accelerated vesting on CRBP’s RSUs if Nishant Saxena is terminated?
Yes. If Corbus terminates Nishant Saxena’s service without cause after the first vesting date, a prorated portion of the next tranche of RSUs will vest. The remaining unaccelerated RSUs are forfeited upon such a termination of service.
What are the key terms of the 192,300 stock options granted by CRBP?
The 192,300 stock options have an exercise price of $11.51 per share and expire on May 21, 2036. Twenty-five percent vests on May 21, 2027, with the remaining 75% vesting in equal monthly installments over 36 months beginning June 21, 2027.
Are the new Corbus (CRBP) equity awards to Nishant Saxena part of a plan?
Yes. The annual option award for 192,300 shares was made under Corbus Pharmaceuticals’ 2024 Equity Compensation Plan. The plan specifies the vesting structure, including the initial 25% cliff vest and subsequent 36 monthly vesting installments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
